ArticlePharmacy (Basel, Switzerland)2022

Adherence to and Persistence with Adalimumab Therapy among Swedish Patients with Crohn's Disease.

Yifei Liu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.